Rapid selection of a cefiderocol-resistant<i>Escherichia coli</i>producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor-Reference-Cited by-同舟云学术

Rapid selection of a cefiderocol-resistantEscherichia coliproducing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor

Published:2023-03-02 Issue:4 Volume:78 Page:1125-1127
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Jousset Agnès B¹²³,Poignon Corentin¹,Yilmaz Seher⁴,Bleibtreu Alexandre⁵⁶^ORCID,Emeraud Cécile¹²³,Girlich Delphine¹,Naas Thierry¹²³^ORCID,Robert Jérôme⁴⁵,Bonnin Rémy A¹²^ORCID,Dortet Laurent¹²³^ORCID

Affiliation:

1. Team ‘Resist’ UMR1184 ‘Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB)’, INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Faculty of Medicine , Le Kremlin-Bicêtre , France

2. Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae , Bicêtre Hospital, Le Kremlin-Bicêtre , France

3. Bacteriology-Hygiene Unit, Assistance Publique-Hôpitaux de Paris, AP-HP Paris-Saclay, Hôpital Bicêtre , Le Kremlin-Bicêtre , France

4. Bacteriology-Hygiene, AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière , Paris , France

5. Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses , Cimi-Paris, Équipe 2, Paris , France

6. Service de Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, AP-HP. Sorbonne Université , Paris , France

Funder

French National Reference Center for antimicrobial resistance

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/article-pdf/78/4/1125/49727884/dkad004.pdf

Reference11 articles.

1. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin;Sato;Clin Infect Dis,2019

2. Progressive development of cefiderocol resistance in Escherichia coli during therapy is associated with increased blaNDM-5 copy number and gene expression;Simner;Clin Infect Dis,2021

3. Case report and genomic analysis of cefiderocol-resistant Escherichia coli clinical isolates;Price;Am J Clin Pathol,2022

4. Clinical evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in Enterobacter cloacae complex following exposure to cefepime;Shields;Clin Infect Dis,2020

5. Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA;Klein;Clin Infect Dis,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond;Clinical Infectious Diseases;2024-01-30

2. Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens;npj Antimicrobials and Resistance;2023-12-20

3. Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory;Antibiotics;2023-12-05

4. Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy;Emerging Infectious Diseases;2023-11

5. Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence;Annals of Intensive Care;2023-06-15